论文期刊

取消

高级检索

检索历史清除

首页> The Journal of asthma : official journal of the Association for the Care of Asthma> Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene<sup>®</sup> Mist): a two-stage randomized controlled trial.

Long-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene<sup>®</sup> Mist): a two-stage randomized controlled trial.

导出 LinkOut

翻译打印收藏纠错

作者： Edward M,Kerwin ^[1] ; Donald P,Tashkin ^[2] ; Phillip E,Korenblat ^[3] ; Leon S,Greos ^[4] ; David S,Pearlman ^[5] ; George W,Bensch ^[6] ; S David,Miller ^[7] ; Tony,Marrs ^[8] ; Mary Z,Luo ^[8] ; Jack Y,Zhang ^[8]

作者单位： Clinical Research Institute of Southern Oregon, Medford, OR, USA. ^[1] Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA. ^[2] The Clinical Research Center, LLC, St Louis, MO, USA. ^[3] Colorado Allergy and Asthma Centers, PC, Centennial, CO, USA. ^[4] Colorado Allergy and Asthma Centers, PC, Denver, CO, USA. ^[5] Allergy, Immunology, and Asthma Medical Group Inc., Stockton, CA, USA. ^[6] Northeast Medical Research Associates, Inc., North Dartmouth, MA, USA. ^[7] Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA, USA. ^[8]

关键词 Inhaled epinephrine NCT01357642 NCT01476904 asthma efficacy hydrofluoroalkane metered-dose inhalers safety

主题词青少年(Adolescent);成年人(Adult);气雾喷射剂(Aerosol Propellants);老年人(Aged);哮喘(Asthma);支气管扩张药(Bronchodilator Agents);心血管疾病(Cardiovascular Diseases);双盲法(Double-Blind Method);肾上腺素(Epinephrine);女(雌)性(Female);人类(Humans);烃类, 氟化(Hydrocarbons, Fluorinated);男(雄)性(Male);定量雾化吸入器(Metered Dose Inhalers);中年人(Middle Aged);单盲法(Single-Blind Method);治疗结果(Treatment Outcome);青年人(Young Adult)

DOI 10.1080/02770903.2020.1713147

PMID 31959019

发布时间 2021-09-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of asthma : official journal of the Association for the Care of Asthma

The Journal of asthma

2021年58卷5期

633-644页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷